Sign Out
Active immunisation with live attenuated virus vaccines (eg measles, mumps or rubella) should be postponed until 3 months after the last administration of human anti-D (Rh) immunoglobulin, as the efficacy of the live attenuated virus vaccine may be impaired.
If human anti-D (Rh) immunoglobulin needs to be administered within 2 - 4 weeks of a live attenuated virus vaccination, then the efficacy of such a vaccination may be impaired.
After injection of immunoglobulin the transitory rise of the various passively transferred antibodies in the patients' blood may result in misleading positive results in serological testing. The results of blood typing and antibody testing including the Coombs or antiglobulin test are significantly affected by the administration of human anti-D (Rh) immunoglobulin.
Incompatibilities: This medicinal product must not be mixed with other medicinal products.
Continue with Google